Download PDF
Thromb Haemost 1997; 78(01): 445-450
DOI: 10.1055/s-0038-1657567
Pathophysiology of von Willebrand factor
Schattauer GmbH Stuttgart

The Significance of Subendothelial von Willebrand Factor

Jacob H Rand
1   Department of Medicine, Mount Sinai School of Medicine, New York, NY
,
Robert W Glanville
4   Department of Research, Shriners Hospital for Crippled Children, Portland, OR
,
Xiao-Xuan Wu
1   Department of Medicine, Mount Sinai School of Medicine, New York, NY
,
Julia M Ross
5   Department of Chemical and Biochemical Engineering, University of Maryland, Baltimore, MD
,
Maurizio Zangari
1   Department of Medicine, Mount Sinai School of Medicine, New York, NY
,
Ronald E Gordon
2   Department of Pathology, Mount Sinai School of Medicine, New York, NY
,
Elaine Schwartz
3   Department of Dermatology, Mount Sinai School of Medicine, New York, NY
,
Barry J Potter
6   Alcohol Research Center, Department of Physiology, Louisiana State University Medical Center, New Orleans, LA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Sporn LA, Marder VJ, Wagner DD. Differing polarity of theconstitutive and regulated secretory pathway for von Willebrand fetor in endothelial cells. J Cell Biol 1989; 108: 1283-1289
    CrossrefPubMedGoogle Scholar
  • 2 Sussman II, Rand JH. Subendothelial deposition of von Willebrand’s factor requires the presence of endothelial cells. J Lab Clin Med 1982; 100: 526-532
    PubMedGoogle Scholar
  • 3 Rand JH, Sussman II, Gordon RE, Chu SV, Solomon V. Localization of factor VIII-related antigen in human vascular subendothelium. Blood 1980; 55: 752-756
    PubMedGoogle Scholar
  • 4 Rand JH, Gordon RE, Sussman II, Chu SV, Solomon V. Electron microscopic localization of factor-VIII-related antigen in adult human blood vessels. Blood 1982; 60: 627-634
    PubMedGoogle Scholar
  • 5 Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636-638
    CrossrefPubMedGoogle Scholar
  • 6 Stel HV, Sakariassen KS, de GrootPG, van MourikJA, Sixma JJ. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 1985; 65: 85-90
    PubMedGoogle Scholar
  • 7 Turitto VT, Weiss HJ, Zimmerman TS, Sussman II. Factor VIII/ von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 823-831
    PubMedGoogle Scholar
  • 8 Rand JH, Wu XX, Uson RR, Potter BJ, Gordon RE. Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium. Am J Pathol 1993; 142: 843-850
    PubMedGoogle Scholar
  • 9 Wu X-X, Gordon RE, Glanville RW, Kuo H-J, Uson RR, Rand JH. Morphological relationships of von Willebrand factor, type VI collagen and fibrillin in human vascular subendothelium. Am J Pathol 1996; 149: 283-291
    PubMedGoogle Scholar
  • 10 Wagner DD, Urban PickeringM, Marder VJ. Von Willebrand protein binds to extracellular matrices independently of collagen. Proc Natl Acad Sci U S A 1984; 81: 471-475
    CrossrefPubMedGoogle Scholar
  • 11 Rand JH, Patel ND, Schwartz E, Zhou SL, Potter BJ. 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 1991; 88: 253-259
    CrossrefPubMedGoogle Scholar
  • 12 Denis C, Baruch D, Kielty CM, Ajzenberg N, Christophe O, Meyer D. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type-VI collagen. Arterioscler Thromb 1993; 13: 398-406
    CrossrefPubMedGoogle Scholar
  • 13 Legrand YJ, Fauvel LafeveF. Molecular mechanism of the interaction of subendothelial microfibrils with blood platelets. Nouv Rev Fr Hematol 1992; 34: 17-25
    PubMedGoogle Scholar
  • 14 Fauvel LafeveF, Arbeille B, de-Romeuf C, Lemesle M, Legrand YJ. Heterogeneity of microfibrils: role of thrombospondin-microfibrils in the thrombogenicity of the subendothelium. C R Acad Sci III 1996; 319: 333-341
    PubMedGoogle Scholar
  • 15 Rand JH, Badimon L, Gordon RE, Uson RR, Fuster V. Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location. Arteriosclerosis 1987; 07: 287-291
    CrossrefPubMedGoogle Scholar
  • 16 Bahnak BR, Wu QY, Coulombel L. et al. Expression of von willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA. Journal of Cellular Physiology 1989; 138: 305-310
    CrossrefPubMedGoogle Scholar
  • 17 van derPlas RM, Schiphorst ME, van ZantenGH, Huizinga EG, Vink T, Sixma JJ. Binding of von Willebrand factor to the extracellular matrix and collagen type VI is not mediated by the Al, A2, A3 or D4 domain and is inhibited by MoAb CLB RAg 40. Thromb Haemost. 1997 (in press)
    PubMedGoogle Scholar
  • 18 Zangari M, Kaplan KL, Glanville RW, Rand JH. Reduced thrombogenicity of type VI collagen as compared to type I collagen. Thromb Res 1995; 79: 429-436
    CrossrefPubMedGoogle Scholar
  • 19 Ross JM, Mclntire LV, Moake JL, Rand JH. Platelet adhesion and aggregation on human type VI collagen surface under physiological flow conditions. Blood 1995; 85: 1826-1835
    PubMedGoogle Scholar
  • 20 Alevriadou BR, Moake JL, Turner NA. et al. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 1993; 81: 1263-1276
    PubMedGoogle Scholar
  • 21 Chu ML, Pan TC, Conway D. et al, The structure of type VI collagen. Ann N Y Acad Sci 1990; 580: 55-63
    CrossrefPubMedGoogle Scholar
  • 22 Cruz MA, Yuan HB, Lee JR, Wise RJ, Handin RL. Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF A domain polypeptides. J Biol Chem 1995; 270: 10822-10827
    CrossrefPubMedGoogle Scholar
  • 23 Mayer U, Poschl E, Nischt R. et al. Recombinant expression and properties of the Kunitz-type protease-inhibitor module from human type VI collagen alpha 3(VI) chain. Eur J Biochem 1994; 225: 573-580
    CrossrefPubMedGoogle Scholar
  • 24 Kuo HJ, Keene DR, Glanville RW. The macromolecular structure of type-VI collagen - Formation and stability of filaments. Eur J Biochem 1995; 232: 364-372
    CrossrefPubMedGoogle Scholar
  • 25 Kielty CM, Shuttleworth CA. Fibrillin-containing microfibrils: structure and function in. Int J Biochem Cell Biol 1995; 27: 747-760
    CrossrefPubMedGoogle Scholar
  • 26 Keene DR, Maddox BK, Kuo HJ, Sakai LY, Glanville RW. Extraction of extendable beaded structures and their identification as fibrillin-containing extracellular matrix microfibrils. J Histochem Cytochem 1991; 39: 441-449
    CrossrefPubMedGoogle Scholar
  • 27 Maslen CL, Glanville RW. The molecular basis of Marfan syndrome. DNA Cell Biol 1993; 12: 561-572
    CrossrefPubMedGoogle Scholar
  • 28 Zhang H, Apfelroth SD, Hu W, Davis EC, Sanguineti C, Bonadio J. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 1994; 124: 855-863
    CrossrefPubMedGoogle Scholar
  • 29 Mariencheck MC, Davis EC, Zhang H, Ramirez F, Rosenbloom J, Gibson MA. Fibrillin-1 and fibrillin-2 show temporal and tissue-specific regulation of expression in developing elastic tissue. Connect Tiss Res 1995; 31: 87-97
    CrossrefPubMedGoogle Scholar
  • 30 Gibson MA, Sandberg LB, Grosso LE, Cleary EG. Complementary DNA cloning establishes microfibril-associated glycoprotein (MAGP) to be a discrete component of the elastin-as- sociated microfibrils. J Biol Chem 1991; 266: 7596-7601
    PubMedGoogle Scholar
  • 31 Gibson MA, Hatzinikolas G, Kumaratilake JS, Sandberg LB, Nich oll. Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25). J Biol Chem 1996; 271: 1096-1103
    CrossrefPubMedGoogle Scholar
  • 32 Colombatti A, Poletti A, Bressan GM, Carbone A, Volpin D. Widespread codistribution of glycoprotein gp 115 and elastin in chick eye and other tissues. Coll Relat Res 1987; 07: 259-275
    CrossrefPubMedGoogle Scholar
  • 33 Kobayashi R, Tashima Y, Masuda H. et al. Isolation and characterization of a new 36-kDa microfibril-associated glycoprotein from porcine aorta. J Biol Chem 1989; 264: 17437-17444
    PubMedGoogle Scholar
  • 34 Gibson MA, Hatzinikolas G, Davis EC, Baker E, Sutherland GR. Bovine latent transforming growth factor beta 1-binding protein. Mol Cell Biol 1995; 15: 6932-6942
    CrossrefPubMedGoogle Scholar
  • 35 Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF. Dual role for the latent transforming growth factor-beta binding. J Cell Biol 1995; 131: 539-549
    CrossrefPubMedGoogle Scholar
  • 36 Horrigan SK, Rich CB, Streeten BW, Li ZY, Foster JA. Characterization of an associated microfibril protein through recombinant DNA techniques. J Biol Chem 1992; 267: 10087-10095
    PubMedGoogle Scholar
  • 37 Abrams WR, Ma RI, Kucich U, Bashir MM, Decker S, Tsipouras P. Molecular cloning of the microfibrillar protein MFAP3 and assignment of the gene to human chromosome 5q32-q33.2. Genomics 1995; 26: 47-54
    CrossrefPubMedGoogle Scholar
  • 38 Zhao Z, Lee CC, Jiralerspong S, Juyal RC, Lu F, Baldini A. The gene for a human microfibril-associated glycoprotein is commonly deleted in Smith-Magenis syndrome patients. Hum Mol Genet 1995; 04: 589-597
    CrossrefPubMedGoogle Scholar
  • 39 Gibson MA, Kumaratilake JS, Cleary EG. The protein components of the 12-nanometer microfibrils of elastic and nonelastic tissues. J Biol Chem 1989; 264: 4590-4598
    PubMedGoogle Scholar
  • 40 Mazzucato M, Masotti A, Perris R. et al. Effect of different shear forces on vWF-mediated platelet adhesion and aggregation on collagen type VI. Blood 1996; 88: 29a
    PubMedGoogle Scholar